Quick Order Cart

Cat. No. ARG2064

MARCKS Knockout AGS Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Stomach

  • Disease:

    Adenocarcinoma

MARCKS Knockout AGS Polyclonal Cells are a CRISPR/Cas9-edited population of human gastric adenocarcinoma cells with targeted disruption of the MARCKS gene. MARCKS is an actin-crosslinking protein that sequesters PIP2, and its PKC-mediated phosphorylation, regulated by EGFR/PDGFR and calcium/calmodulin, triggers actin remodeling, cell motility, and exocytosis. This polyclonal knockout model, derived from AGS cells, impairs MARCKS-dependent cytoskeletal reorganization, offering a powerful tool for studying gastric cancer cell migration, invasion, and adhesion. Applications include transwell migration, wound-healing, and immunofluorescence assays to explore metastatic mechanisms and PKC/PI3K/Akt pathway crosstalk.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    AGS

    Sex of Donor

    Female

    Age

    54 years

    Derived From Site

    In situ; Stomach

    Gene Name

    MARCKS

    Gene Identifier

    NCBI Gene ID 4082

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    Ham's F-12

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The MARCKS Knockout AGS Polyclonal Cells are a CRISPR/Cas9-edited heterogeneous population of human AGS gastric adenocarcinoma cells harboring targeted disruption of the MARCKS gene. This polyclonal knockout model maintains the epithelial, adherent nature of the parental AGS line and provides a loss-of-function system for investigating MARCKS-dependent biological processes in a cancer-relevant background.

The AGS cell line, derived from a human gastric adenocarcinoma, is widely utilized as an in vitro model for gastric cancer research. These epithelial cells display adherent monolayer growth and respond to growth factors such as EGF and PDGF, enabling studies of oncogenic signaling, cell migration, and invasion. Their transformed phenotype makes them particularly useful for assessing molecular determinants of gastric cancer metastasis.

MARCKS is an actin-crosslinking protein that sequesters PIP2 at the plasma membrane, modulating cytoskeletal dynamics and membrane-cytoskeleton adhesions. Its function is regulated through phosphorylation by protein kinase C (PKC) in response to upstream receptor tyrosine kinases, including EGFR and PDGFR, as well as Ca2+/calmodulin signaling. Upon PKC-mediated phosphorylation, MARCKS releases PIP2 and dissociates from the membrane, promoting actin remodeling, focal adhesion turnover, cell motility, and exocytosis. Key molecular interactions include direct binding to F-actin, calmodulin, and PIP2, positioning MARCKS as a central integrator of growth factor signals with cytoskeletal effector pathways.

In AGS gastric adenocarcinoma cells, MARCKS contributes to aggressive phenotypes such as enhanced migration and invasion. Disruption of MARCKS in this polyclonal knockout population impairs actin crosslinking and PIP2 sequestration, leading to defective cell spreading, reduced directional motility, and attenuated secretion. This model allows dissection of MARCKS function in EGF- and PDGF-stimulated migration, and its role in coordinating PKC and PI3K/Akt signaling. The cells are also valuable for exploring crosstalk with small GTPases such as Rac and Cdc42 that control lamellipodia formation and cell polarity.

Research applications include transwell migration and invasion assays, wound-healing scratch assays, and live-cell imaging of motility dynamics. The cells can be used for cell adhesion and spreading studies, immunofluorescence to examine actin cytoskeletal organization and focal adhesions, and secretion assays to evaluate MARCKS-mediated exocytosis. Western blotting and phospho-specific antibody detection enable assessment of MARCKS expression and PKC-dependent phosphorylation. For additional information or assay support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)